Advertisement FDA cautions against ExtenZe counterfeit products - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FDA cautions against ExtenZe counterfeit products

The US Food and Drug Administration (FDA) has cautioned the consumers regarding the harmful effects of counterfeit dietary supplement, ExtenZe for male sexual enhancement.

The FDA has asked the consumers not to buy products labeled as ExtenZe with lot numbers 1110075 and F050899.

The agency said the counterfeit product’s packaging is similar to the actual product, but comprises hidden ingredients that can cause serious harm to consumers.

The counterfeit product contains tadalafil, or a combination of tadalafil and sildenafil – active ingredients in FDA-approved prescription medicines for erectile dysfunction.

The ingredients are not listed on the product label.

FDA Center for Drug Evaluation and Research Office of Compliance deputy director Ilisa Bernstein said these types of products are typically promoted for sexual enhancement, weight loss, and body building, and are often represented as being ‘all natural.’